High Purity N-Desmethyl Imatinib (CAS 404844-02-6): Your Trusted Manufacturer & Supplier in China

Discover N-Desmethyl Imatinib (CAS 404844-02-6), a critical pharmaceutical intermediate and metabolite of Imatinib. As a leading manufacturer and supplier in China, we offer high-purity products for your research and development needs. Get a competitive price and secure your supply chain today.

Get a Quote & Sample

Why Choose Our N-Desmethyl Imatinib?

Uncompromising Quality & Purity

We are a dedicated manufacturer in China committed to delivering N-Desmethyl Imatinib with superior purity. Our rigorous quality control ensures that every batch meets the exacting standards required for pharmaceutical development and advanced research applications.

Stable Supply Chain & Competitive Pricing

Secure your supply of N-Desmethyl Imatinib from a dependable manufacturer. We offer competitive pricing for bulk orders and consistent availability, ensuring your projects proceed without interruption. Inquire about current price and availability for your purchase needs.

Expertise in Pharmaceutical Intermediates

Leverage our extensive experience as a supplier of N-Desmethyl Imatinib. Our deep understanding of pharmaceutical intermediates positions us as your go-to partner for high-value chemical solutions, directly from our China-based operations.

Key Applications of N-Desmethyl Imatinib

Pharmaceutical Reference Standard

N-Desmethyl Imatinib serves as a vital reference standard for analytical testing and quality control in pharmaceutical manufacturing, ensuring the integrity of Imatinib-related products.

Drug Metabolism Studies

Crucial for researchers studying the metabolic pathways and pharmacokinetics of Imatinib, providing insights into drug efficacy and potential interactions.

API Synthesis Intermediate

As a key intermediate, it plays a significant role in the complex synthesis of Active Pharmaceutical Ingredients (APIs), contributing to the development of novel therapeutics.

Oncology Research

Essential for R&D in oncology, particularly in understanding resistance mechanisms and developing next-generation tyrosine kinase inhibitors.